Biomica

Biomica
Biomica is developing a novel microbiome-based platform for the treatment of cancer.
About
What does Biomica do?
Biomica is a clinical-stage biopharmaceutical company focused on developing microbiome-based therapeutics for cancer. Their platform leverages a deep understanding of the microbiome's role in cancer and its response to immunotherapy to create novel drug candidates. They aim to address unmet needs in oncology by offering new treatment options.
What is Biomica's revenue?
StartupHub estimates Biomica's annual revenue at $1.2M (range $667K to $1.9M, 64% confidence), based on comparable companies in the sector.
What is Biomica's valuation?
StartupHub estimates Biomica's effective valuation at $76.4M (range $50.0M to $120.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Biomica raised?
Biomica has raised a total of $20M in funding. The most recent round on record is Funding Round.
Where is Biomica headquartered?
Biomica is headquartered in Rehovot, Israel.
When was Biomica founded?
Biomica was founded in 2018.
What industry does Biomica operate in?
Biomica operates in Life Sciences, Biotech, Drug Discovery, Microbiome Engineering, Oncology, Clinical Trials.
How many employees does Biomica have?
Biomica has approximately 7 people on record.
No comments yet. Be the first to share your take.